NCT00028587View on ClinicalTrials.gov

PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

April 30, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Given IV

DRUG

paclitaxel

Given IV

DRUG

carboplatin

Given IV

OTHER

laboratory biomarker analysis

Optional correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00028587 - PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter